Tissue Repair Ltd
TRP
Rank in Stocks
#30556
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Share Price
$0.0899847
Last synced: 2026-11-10
Market Cap
$4.79M
Change (1 day)
0.00%
Change (1 year)
-54.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tissue Repair Ltd (TRP)
Category
Healthcare
EPS for Tissue Repair Ltd (TRP)
EPS as of June 2026 TTM: $-0.06
According to Tissue Repair Ltd's latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.05, equal to its 2024 EPS of $-0.05.
EPS history for Tissue Repair Ltd from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | 20.00% |
| 2025 | $-0.05 | 0.88% |
| 2024 | $-0.05 | -0.65% |
| 2023 | $-0.05 | -39.39% |
| 2022 | $-0.08 | 357.23% |
| 2021 | $-0.02 | 181.36% |
| 2020 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 1,383.33% |
US
|
|
| $15.66 | -26,200.00% |
US
|
|
| $-7.07 | 11,683.33% |
US
|
|
| $-5.29 | 8,716.67% |
AU
|
|
| $12.73 | -21,320.33% |
BE
|
Questions about Tissue Repair Ltd's earnings per share (EPS)
What is Tissue Repair Ltd's earnings per share (EPS)?
Tissue Repair Ltd's earnings per share (EPS) over the last twelve months is $-0.06, as of Jun 2026.
What was Tissue Repair Ltd's earnings per share (EPS) in 2025?
In 2025, Tissue Repair Ltd's earnings per share (EPS) was $-0.05, compared with $-0.05 in 2024.
How has Tissue Repair Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Tissue Repair Ltd's earnings per share (EPS) was highest in 2020 ($-0.01) and lowest in 2022 ($-0.08).
How does Tissue Repair Ltd's earnings per share (EPS) compare with similar companies?
Tissue Repair Ltd's earnings per share (EPS) ($-0.06) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.